BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitha E, Krivan G, Jacobs F, Nagler A, Alrabaa S, Mykietiuk A, Kenwright A, Le Pogam S, Clinch B, Vareikiene L. Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients. Infect Dis Ther 2019;8:613-26. [PMID: 31667696 DOI: 10.1007/s40121-019-00271-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhan Y, Chen X, Guan W, Guan W, Yang C, Pan S, Wong SS, Chen R, Ye F. Clinical impact of nosocomial infection with pandemic influenza A (H1N1) 2009 in a respiratory ward in Guangzhou. J Thorac Dis 2021;13:5851-62. [PMID: 34795934 DOI: 10.21037/jtd-21-897] [Reference Citation Analysis]
2 Angrini M, Varthaman A, Garcia-Verdugo I, Sallenave JM, Alifano M, Cremer I. To Vaccinate or not: Influenza Virus and Lung Cancer Progression. Trends Cancer 2021;7:573-6. [PMID: 33712391 DOI: 10.1016/j.trecan.2021.02.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Jordie EB, Gibiansky L, Knab T, Lemenuel-Diot A, Ravva P, Zwanziger E, Jolivet S, Bhardwaj R, Hernández-Sánchez J, Nasmyth-Miller C, Sturm S. Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy. Br J Clin Pharmacol 2021. [PMID: 34449090 DOI: 10.1111/bcp.15059] [Reference Citation Analysis]
4 Holmes EC, Hurt AC, Dobbie Z, Clinch B, Oxford JS, Piedra PA. Understanding the Impact of Resistance to Influenza Antivirals. Clin Microbiol Rev 2021;34:e00224-20. [PMID: 33568554 DOI: 10.1128/CMR.00224-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li L, Liu J, Qin K. Comparison of double-dose vs standard-dose oseltamivir in the treatment of influenza: A systematic review and meta-analysis. J Clin Pharm Ther 2020;45:918-26. [PMID: 32497319 DOI: 10.1111/jcpt.13203] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Mhamdi Z, Fausther-Bovendo H, Uyar O, Carbonneau J, Venable MC, Abed Y, Kobinger G, Boivin G, Baz M. Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus. Microorganisms 2020;8:E1968. [PMID: 33322333 DOI: 10.3390/microorganisms8121968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zaraket H, Hurt AC, Clinch B, Barr I, Lee N. Burden of influenza B virus infection and considerations for clinical management. Antiviral Res 2021;185:104970. [PMID: 33159999 DOI: 10.1016/j.antiviral.2020.104970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ison MG, Hirsch HH. Letter to the Editor. Transplantation 2021;105:e397. [PMID: 34818308 DOI: 10.1097/TP.0000000000003853] [Reference Citation Analysis]
9 Bautista F, Engelhard D, Rizzari C, Baka M, Saavedra-Lozano J, Lopez-Medina E, Nasmyth-Miller C, Hernández-Sánchez J, Sturm S. Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza. Open Forum Infect Dis 2019;6:ofz430. [PMID: 31660381 DOI: 10.1093/ofid/ofz430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Maher KR, Bouligny IM, Yeager AM. Prevention and management of infections after exposure to ionising radiation. J Radiol Prot 2021;41. [PMID: 34265748 DOI: 10.1088/1361-6498/ac14d3] [Reference Citation Analysis]
11 Sturm S, Lemenuel-Diot A, Patel K, Gibiansky L, Bhardwaj R, Smith PF, Dang S, Zwanziger E, Nasmyth-Miller C, Ravva P. Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization. Br J Clin Pharmacol 2021;87:1359-68. [PMID: 32808306 DOI: 10.1111/bcp.14523] [Cited by in F6Publishing: 2] [Reference Citation Analysis]